Skip to main content
. 2017 Nov 10;66(3):428–436. doi: 10.1093/cid/cix772

Figure 2.

Figure 2.

Women receiving lopinavir/ritonavir (LPV/r)–based combination antiretroviral therapy (cART) have higher plasma estradiol in comparison with women receiving efavirenz (EFV)–based cART. Loge-transformed levels of plasma progesterone (A) and estradiol (B) across pregnancy in human immunodeficiency virus–infected women receiving EFV or LPV/r-based cART.